XuanZhu Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:XuanZhu Pharma Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011864
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
XuanZhu Pharma Co Ltd (XuanZhu), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd is a healthcare company that research, develops, manufactures and sales drugs. The company’s products include anti-infective drugs apapenem and benapenem; anti-acid drug anaprazole sodium, anti-diabetic drug imigliptin hydrochloride and anti-hypertensive drug tylerdipine hydrochloride. Its technology platforms include drug analysis lab, preparation research lab, lab for crystal form study and salt selection, BSL-2 lab, lab for pharmacokinetics and drug metabolism among others. The company provides products in the therapeutic areas including cardiology, oncology, and others. XuanZhu is headquartered in Jinan, China.

XuanZhu Pharma Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 10
Covance Enters into Co-Development Agreement with Sihuan Pharma 11
Acquisition 12
Sihuan Pharma Acquires 40% Stake in XuanZhu Pharma 12
XuanZhu Pharma Co Ltd – Key Competitors 13
XuanZhu Pharma Co Ltd – Key Employees 14
XuanZhu Pharma Co Ltd – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
08/04/2016: CFDA Granted Approval of Phase II/III Clinical Trials for Imigliptin Hydrochloride 16
07/28/2016: Sihuan Pharmaceutical Secures CFDA approval for Imigliptin Dihydrochloride Phase II/III Clinical Trials 17
Clinical Trials 18
Dec 14, 2016: CFDA Granted Approval forPhase I/II/III Clinical Trials of Sihuan Pharmaceutical’s Internally Developed Innovative Patented New Drug – Fadanafil 18
Aug 26, 2016: CFDA Granted Approval of Phase I-III Clinical Trials for Sirotinib (XZP – 5491) 19
Mar 21, 2016: CFDA Granted Approval for Clinical Trials of Internally-developed Category 1.1 Innovative Anti-diabetic Drug – Janagliflozin 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
XuanZhu Pharma Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 10
Covance Enters into Co-Development Agreement with Sihuan Pharma 11
Sihuan Pharma Acquires 40% Stake in XuanZhu Pharma 12
XuanZhu Pharma Co Ltd, Key Competitors 13
XuanZhu Pharma Co Ltd, Key Employees 14

★海外企業調査レポート[XuanZhu Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Euromoney Institutional Investor PLC:企業の戦略・SWOT・財務分析
    Euromoney Institutional Investor PLC - Strategy, SWOT and Corporate Finance Report Summary Euromoney Institutional Investor PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • STMicroelectronics N.V. (STM)-医療機器分野:企業M&A・提携分析
    Summary STMicroelectronics N.V. (ST) is a microelectronics company that designs, develops, manufactures, and markets a broad range of products for analog, digital, and mixed-signal applications. It offers standard commodity components, custom devices and semi-custom devices, application-specific int …
  • Nice-Pak Products, Inc.:企業の戦略・SWOT・財務情報
    Nice-Pak Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nice-Pak Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Burke-Divide Electric Cooperative Inc:企業の戦略的SWOT分析
    Burke-Divide Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • GAIL (India) Limited:企業の戦略・SWOT・財務分析
    GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report Summary GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • CompuGroup Medical Deutschland AG (COP):医療機器:M&Aディール及び事業提携情報
    Summary CompuGroup Medical Deutschland AG (CGM) is a provider of medical software products and healthcare services. The company provides products such as communication solutions, software assisted medicine, dentist information systems, ambulatory information systems, drug safety and patient marketin …
  • Firstmark Corporation:企業の戦略・SWOT・財務情報
    Firstmark Corporation - Strategy, SWOT and Corporate Finance Report Summary Firstmark Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bangchak Corporation PCL (BCP):企業の財務・戦略的SWOT分析
    Bangchak Corporation PCL (BCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • SRS Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary SRS Medical Systems Inc (SRS Medical) is a medical device company that designs, manufactures and markets diagnostics and disposable products. The company offers spanner, urocuff test systems, urodynamic systems, uroflows, uroscan bladder ultrasound systems and disposables. Its disposables co …
  • Link Healthcare Pty Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Link Healthcare Pty Ltd (LINK), a subsidiary of Clinigen Group Plc, is a healthcare solution provider that provides generic products. The company offers therapeutic products, prescription, OTC medicines and medical devices in various therapeutic areas. It offers products such as relistor, an …
  • ElectraNet Pty Ltd:企業の戦略的SWOT分析
    ElectraNet Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Aboitiz Power Corporation (AP):電力:M&Aディール及び事業提携情報
    Summary Aboitiz Power Corporation (Aboitiz Power) a subsidiary of Aboitiz Equity Ventures Inc is a holding company that operates privately-owned generation companies and distribution utilities. Its power generation portfolio sources include hydropower, geothermal, coal, and oil. The company sells it …
  • Exmar NV (EXM):企業の財務・戦略的SWOT分析
    Summary Exmar NV (Exmar) a subsidiary of Compagnie Maritime Belge SA, operates as a shipping and energy supply chain solutions provider. The company's service portfolio includes liquefied natural gas (LNG), offshore, liquid petroleum gas (LPG) and supporting services. Its LNG segment offers floating …
  • Mitek Systems Inc (MITK):企業の財務・戦略的SWOT分析
    Summary Mitek Systems Inc (Mitek) is a technology company that develops and markets payment and fraud prevention software products. The company offers products such as Mobile Verify, Mobile Docs, Mobile Fill, Mobile Deposit and Multi Check Capture. Its Mobile Verify is a Mitek's ID verification solu …
  • Galera Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Galera Therapeutics Inc (Galera Therapeutics) is a clinical-stage biotechnology company that discovers and develops novel cancer treatments. The company also concentrates on the prevention of radiation-induced toxicity including mucositis and the treatment of cancer. Its GC4419 is a selectiv …
  • Dynegy Inc:発電所・企業SWOT分析
    Dynegy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • EGYPTAIR Holding Company:企業の戦略・SWOT・財務分析
    EGYPTAIR Holding Company - Strategy, SWOT and Corporate Finance Report Summary EGYPTAIR Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nipro Corp (8086):製薬・医療:M&Aディール及び事業提携情報
    Summary Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary …
  • Hong Leong Group:企業の戦略・SWOT・財務情報
    Hong Leong Group - Strategy, SWOT and Corporate Finance Report Summary Hong Leong Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆